End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.09 CAD | 0.00% | +5.88% | -10.00% |
Apr. 01 | Willow Biosciences Narrows 2023 Loss YOY | MT |
Mar. 29 | Willow Biosciences Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 821K 600K | Sales 2023 | 1.17M 857K | Capitalization | 12.42M 9.08M |
---|---|---|---|---|---|
Net income 2022 | -14M -10.23M | Net income 2023 | -13M -9.5M | EV / Sales 2022 | -0.95 x |
Net cash position 2022 | 15.01M 10.97M | Net cash position 2023 | 1.63M 1.19M | EV / Sales 2023 | 9.21 x |
P/E ratio 2022 |
-0.96
x | P/E ratio 2023 |
-0.95
x | Employees | 19 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 72.66% |
1 week | +5.88% | ||
Current month | -10.00% | ||
3 months | -21.74% | ||
Current year | -10.00% |
Managers | Title | Age | Since |
---|---|---|---|
Chris Savile
CEO | Chief Executive Officer | - | 19-04-11 |
Travis Doupe
DFI | Director of Finance/CFO | - | 19-04-11 |
Trish Choudhary
CTO | Chief Tech/Sci/R&D Officer | - | 19-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Lalonde
CHM | Chairman | 63 | 23-02-20 |
Donald Archibald
BRD | Director/Board Member | 63 | 19-04-11 |
Director/Board Member | 51 | 19-04-11 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 0.09 | 0.00% | 18,151 |
24-04-22 | 0.09 | 0.00% | 34,502 |
24-04-18 | 0.09 | +5.88% | 10,000 |
24-04-17 | 0.085 | 0.00% | 3,000 |
24-04-16 | 0.085 | 0.00% | 253,000 |
End-of-day quote Toronto S.E., April 22, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-10.00% | 8.37M | |
-2.86% | 87.37B | |
+4.08% | 41.01B | |
-25.35% | 28.08B | |
+54.31% | 24.72B | |
-4.52% | 17.47B | |
-42.09% | 11.69B | |
-17.77% | 11.6B | |
-12.10% | 11.56B | |
+1.72% | 8.44B |
- Stock Market
- Equities
- WLLW Stock